Literature DB >> 3368026

Cerebral metabolism of plasma [14C]palmitate in awake, adult rat: subcellular localization.

J M Gnaedinger1, J C Miller, C H Latker, S I Rapoport.   

Abstract

Following intravenous injection of [U-14C]palmitate in awake adult rats, whole brain radioactivity reached a broad maximum between 15-60 min, then declined rapidly to reach a relatively stable level between 4 hr and 20 hr. At 44 hr total radioactivity was 57% of the 4 hr value (p less than 0.05). About 50% of palmitate which entered the brain from the blood was oxidized rapidly, producing 14C-labeled water-soluble components which later left the cytosol. Radioactivity in the cytosolic fraction peaked at 45 min and then declined, coincident with the decline in total brain radioactivity. Membrane fractions were rapidly labeled to levels which remained relatively stable from 1 to 44 hr. Increases in the relative distributions of radioactivity were seen between 1 and 4 hr for the microsomal and mitochondrial fractions, and beyond 4 hr for the synaptic and myelin membrane fractions (p less than 0.05). Radioactivity in membrane fractions was 80-90% lipid, 5-13% water-soluble components and 3-17% protein. The proportion of label in membrane-associated protein increased with time. Proportions of radioactivity in the combined membrane fractions increased from 65% to 76% to 80% at 4, 20 and 44 hr, respectively. The results show that plasma-derived palmitate enters oxidative and synthetic pathways to an equal extent, immediately after entry into the brain. At and after 4 hr, the radiolabel resides predominantly in stable membrane lipids and protein. Brain radioactivity at 4 hr can be used therefore, to examine incorporation of palmitate into lipids in vivo, in different experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368026     DOI: 10.1007/bf00971850

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Activation and oxidation of long chain fatty acids by rat brain.

Authors:  P M VIGNAIS; C H GALLAGHER; I ZABIN
Journal:  J Neurochem       Date:  1958       Impact factor: 5.372

2.  Effect of chronic electrical stimulation on incorporation of [1-14C]oleate into glycerolipids of mouse brain.

Authors:  G Y Sun
Journal:  J Neurochem       Date:  1977-06       Impact factor: 5.372

3.  Metabolism of arachidonoyl phosphoglycerides in mouse brain subcellular fractions.

Authors:  G Y Sun; K L Su
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

4.  CNS and fatty acid metabolism.

Authors:  J J Spitzer
Journal:  Physiologist       Date:  1973-02

5.  Fatty acid transport into the brain.

Authors:  G A Dhopeshwarkar; C Subramanian; D H McConnell; J F Mead
Journal:  Biochim Biophys Acta       Date:  1972-02-11

6.  Is there a blood-brain relationship for saturated fatty acids during development?

Authors:  J M Bourre; N Gozlan-Devillierre; O Daudu; N Baumann
Journal:  Biol Neonate       Date:  1978

7.  Palmitate incorporation into different brain regions in the awake rat.

Authors:  A S Kimes; D Sweeney; E D London; S I Rapoport
Journal:  Brain Res       Date:  1983-09-12       Impact factor: 3.252

8.  Metabolism of palmitic acid in the subcellular fractions of mouse brain.

Authors:  G Y Sun; L A Horrocks
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

9.  In vitro acylation of rat brain myelin proteolipid protein.

Authors:  L E Townsend; D Agrawal; J A Benjamins; H C Agrawal
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  Distribution of radioactivity in myelin lipids following subcutaneous injection of [14C]stearate.

Authors:  N Gozlan-Devillierre; N Baumann; J M Bourre
Journal:  Biochim Biophys Acta       Date:  1978-03-30
View more
  10 in total

Review 1.  Fat sensing and metabolic syndrome.

Authors:  Jang H Youn
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

2.  Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism.

Authors:  Mikhail Y Golovko; Thad A Rosenberger; Nils J Faergeman; Søren Feddersen; Nelson B Cole; Ingrid Pribill; Johannes Berger; Robert L Nussbaum; Eric J Murphy
Journal:  Biochemistry       Date:  2006-06-06       Impact factor: 3.162

3.  Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse.

Authors:  C R Jones; T Arai; S I Rapoport
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

4.  Intravenously injected [1-14C]arachidonic acid targets phospholipids, and [1-14C]palmitic acid targets neutral lipids in hearts of awake rats.

Authors:  E J Murphy; T A Rosenberger; C B Patrick; S I Rapoport
Journal:  Lipids       Date:  2000-08       Impact factor: 1.880

5.  Determining the Bioenergetic Capacity for Fatty Acid Oxidation in the Mammalian Nervous System.

Authors:  Cory J White; Jieun Lee; Joseph Choi; Tiffany Chu; Susanna Scafidi; Michael J Wolfgang
Journal:  Mol Cell Biol       Date:  2020-04-28       Impact factor: 4.272

6.  Erucic acid is differentially taken up and metabolized in rat liver and heart.

Authors:  Cameron C Murphy; Eric J Murphy; Mikhail Y Golovko
Journal:  Lipids       Date:  2008-03-19       Impact factor: 1.880

7.  Mouse Strain Impacts Fatty Acid Uptake and Trafficking in Liver, Heart, and Brain: A Comparison of C57BL/6 and Swiss Webster Mice.

Authors:  D R Seeger; E J Murphy
Journal:  Lipids       Date:  2016-01-21       Impact factor: 1.880

Review 8.  A model for fatty acid transport into the brain.

Authors:  James A Hamilton; Kellen Brunaldi
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 9.  Cerebral Metabolic Changes During Sleep.

Authors:  Nadia Nielsen Aalling; Maiken Nedergaard; Mauro DiNuzzo
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-16       Impact factor: 5.081

10.  Increased brain fatty acid uptake in metabolic syndrome.

Authors:  Anna Karmi; Patricia Iozzo; Antti Viljanen; Jussi Hirvonen; Barbara A Fielding; Kirsi Virtanen; Vesa Oikonen; Jukka Kemppainen; Tapio Viljanen; Letizia Guiducci; Merja Haaparanta-Solin; Kjell Någren; Olof Solin; Pirjo Nuutila
Journal:  Diabetes       Date:  2010-06-21       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.